Remitting seronegative symmetrical synovitis with pitting edema syndrome in individuals with type 2 diabetes mellitus or impaired glucose tolerance

Highlights • An association between remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome and insulin or dipeptidyl peptidase-4 (DPP4) inhibitor therapy was previously reported. • We report four cases of RS3PE syndrome with type 2 diabetes mellitus or impaired glucose tole...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes research and clinical practice 2015-10, Vol.110 (1), p.e5-e8
Main Authors: Oyama, Kohta, Taniguchi, Jun-ichi, Goto, Rieko, Matsui, Kunihiko
Format: Article
Language:English
Subjects:
Aged
Diabetes mellitus
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - diagnosis
Diabetes Mellitus, Type 2 - drug therapy
Edema - complications
Edema - diagnosis
Endocrinology & Metabolism
Female
Glucose Intolerance - complications
Glucose Intolerance - diagnosis
Humans
Hypoglycemic Agents - therapeutic use
Impaired glucose tolerance
Male
Middle Aged
Remitting seronegative symmetrical synovitis with pitting edema
Syndrome
Synovitis - complications
Synovitis - diagnosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • An association between remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome and insulin or dipeptidyl peptidase-4 (DPP4) inhibitor therapy was previously reported. • We report four cases of RS3PE syndrome with type 2 diabetes mellitus or impaired glucose tolerance (IGT) without insulin or DPP4 inhibitor medication. • RS3PE syndrome might be associated with diabetes, regardless of type or anti-diabetes therapies.
ISSN:0168-8227
1872-8227
DOI:10.1016/j.diabres.2015.06.007